Baird Medical Investment Holdings (BDMD) Income Statement: Revenue & Earnings

Baird Medical Investment Holdings Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Baird Medical Investment Holdings Limited income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	37.04	31.46	35.09	27.72	18.12
Cost of Revenue	4.38	4.23	7.05	4.54	2.51
Gross Profit	32.65	27.23	28.04	23.18	15.61
Operating Expenses
Research & Development	6.17	4.27	3.86	1.04	0.75
Selling, General & Administrative	9.96	11.09	10.15	10.22	4.60
Operating Expenses	17.34	15.37	13.03	10.09	5.94
Operating Income	15.32	11.86	15.01	13.09	9.67
Other Income/Expense
Interest Income	0.00	0.00	0.01	0.00	0.00
Interest Expense	0.58	-0.29	0.30	0.15	-0.16
Other Income/Expense	-0.65	0.78	-0.19	-0.34	-3.77
Income
Income Before Tax	14.09	12.36	14.52	12.61	9.58
Income Tax Expense	1.49	1.70	1.75	2.42	2.43
Net Income	12.45	10.55	12.57	10.09	7.10
Net Income - Continuous Operations	12.60	10.66	12.77	10.18	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	16.17	12.88	16.29	14.16	10.28
EBIT	14.66	11.86	14.82	12.76	9.67
Depreciation & Amortization	1.51	1.01	1.47	1.40	0.61
Earnings Per Share
Basic EPS	-	-	-	-	-
Diluted EPS	-	-	-	-	-
Basic Shares Outstanding	25.56	25.56	25.56	25.56	0.00
Diluted Shares Outstanding	25.63	25.56	25.56	25.56	0.00